Medicines adherence remains a massive problem for healthcare systems, the pharmaceutical industry and patients, leading to increased disease burden and personal risks.
The pharmaceutical industry is waking up to the enormous potential offered by social media and other online data sources for informing better decisions around drug development and commercializa
Empowered patients, or citizen experts as they are often called, are becoming one of the most powerful forces in healthcare, which means the pharmaceutical industry must learn to effectively en
As the UK health and social care systems look to improve patient services in the primary care setting, attention must turn to how carers, an army of around 6.5 million unpaid contributors, can
The confluence of personalised medicine and the digital information age means that a much greater volume of information is required by physicians in successfully treating patients.
The pharma industry of today understands that good real-world patient outcomes can carry as much weight as robust regulatory data, so understanding drug use beyond the clinical trial setting is